Literature DB >> 7036276

Adjuvant chemotherapy in breast cancer.

R Nissen-Meyer, K Kjellgren, B Mansson.   

Abstract

One single course of i.v. cyclophosphamide (30 mg/kg) was given over a 6-day period to 559 mastectomized patients. During a follow-up period of up to 15 years, 241 recurrence and 234 deaths are registered in this group, and 294 recurrences and 283 deaths in the randomized control group of 577 patients. Analysis of the life-table curves shows an increased cure rate of about 10%.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036276     DOI: 10.1007/978-3-642-81685-7_24

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  6 in total

1.  Controversies in the medical management of breast cancer.

Authors:  I E Smith
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 2.  Adjuvant chemotherapy for early breast cancer.

Authors:  I E Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

3.  Epileptic seizures in general practice.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-05

4.  Adjuvant chemotherapy for early breast cancer.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

5.  Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.

Authors: 
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

6.  Adjuvant therapy in colorectal cancer.

Authors:  A K House
Journal:  J R Soc Med       Date:  1984-06       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.